Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A.

[1]  Hui Zhao,et al.  Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[2]  M. Pagano,et al.  Dual mode of degradation of Cdc25 A phosphatase , 2002, The EMBO journal.

[3]  P. Jeggo,et al.  Chk2 Is a Tumor Suppressor That Regulates Apoptosis in both an Ataxia Telangiectasia Mutated (ATM)-Dependent and an ATM-Independent Manner , 2002, Molecular and Cellular Biology.

[4]  A. Millar,et al.  Genes involved in DNA repair are mutational targets in endometrial cancers with microsatellite instability. , 2002, Cancer research.

[5]  K. Okazaki,et al.  Chk1 is activated transiently and targets Cdc25A for degradation at the Xenopus midblastula transition , 2002, The EMBO journal.

[6]  Bo Xu,et al.  Convergence of the Fanconi Anemia and Ataxia Telangiectasia Signaling Pathways , 2002, Cell.

[7]  T. Honjo,et al.  DNA Double-Strand Breaks , 2002, The Journal of experimental medicine.

[8]  L. Iyer,et al.  Determination of Substrate Motifs for Human Chk1 and hCds1/Chk2 by the Oriented Peptide Library Approach* , 2002, The Journal of Biological Chemistry.

[9]  J. Bartek,et al.  The DNA damage-dependent intra–S phase checkpoint is regulated by parallel pathways , 2002, Nature Genetics.

[10]  T. Volkert,et al.  E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. , 2002, Genes & development.

[11]  S. Schwartz,et al.  Somatic mutations in the DNA damage-response genes ATR and CHK1 in sporadic stomach tumors with microsatellite instability. , 2001, Cancer research.

[12]  R. Abraham.  Cell cycle checkpoint signaling through the ATM and ATR kinases. , 2001, Genes & development.

[13]  H. Piwnica-Worms,et al.  ATR-Mediated Checkpoint Pathways Regulate Phosphorylation and Activation of Human Chk1 , 2001, Molecular and Cellular Biology.

[14]  N. Mailand,et al.  DNA damage-activated kinase Chk2 is independent of proliferation or differentiation yet correlates with tissue biology. , 2001, Cancer research.

[15]  J. Peters,et al.  A Conserved Cyclin-Binding Domain Determines Functional Interplay between Anaphase-Promoting Complex–Cdh1 and Cyclin A-Cdk2 during Cell Cycle Progression , 2001, Molecular and Cellular Biology.

[16]  Bo Xu,et al.  Involvement of Brca1 in S-Phase and G2-Phase Checkpoints after Ionizing Irradiation , 2001, Molecular and Cellular Biology.

[17]  N. Mailand,et al.  The ATM–Chk2–Cdc25A checkpoint pathway guards against radioresistant DNA synthesis , 2001, Nature.

[18]  K. Khanna,et al.  DNA double-strand breaks: signaling, repair and the cancer connection , 2001, Nature Genetics.

[19]  Vanesa Gottifredi,et al.  p53 Down-Regulates CHK1 through p21 and the Retinoblastoma Protein , 2001, Molecular and Cellular Biology.

[20]  Y. Kubota,et al.  Eukaryotic DNA replication: from pre-replication complex to initiation complex. , 2000, Current opinion in cell biology.

[21]  M. Kastan,et al.  The many substrates and functions of ATM , 2000, Nature Reviews Molecular Cell Biology.

[22]  A. Kumagai,et al.  Requirement for Atr in phosphorylation of Chk1 and cell cycle regulation in response to DNA replication blocks and UV-damaged DNA in Xenopus egg extracts. , 2000, Genes & development.

[23]  A. Kumagai,et al.  Claspin, a novel protein required for the activation of Chk1 during a DNA replication checkpoint response in Xenopus egg extracts. , 2000, Molecular cell.

[24]  M. Loda,et al.  Role of the Cdc25A phosphatase in human breast cancer. , 2000, The Journal of clinical investigation.

[25]  J. Gautier,et al.  Reconstitution of an ATM-dependent checkpoint that inhibits chromosomal DNA replication following DNA damage. , 2000, Molecular cell.

[26]  M. Molinari,et al.  Human Cdc25 A inactivation in response to S phase inhibition and its role in preventing premature mitosis , 2000, EMBO reports.

[27]  Y. A. Minamishima,et al.  Aberrant cell cycle checkpoint function and early embryonic death in Chk1(-/-) mice. , 2000, Genes & development.

[28]  S. Elledge,et al.  Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. , 2000, Genes & development.

[29]  N. Mailand,et al.  Rapid destruction of human Cdc25A in response to DNA damage. , 2000, Science.

[30]  J. Sarkaria,et al.  The radiosensitizing agent 7-hydroxystaurosporine (UCN-01) inhibits the DNA damage checkpoint kinase hChk1. , 2000, Cancer research.

[31]  Edward A. Sausville,et al.  The Chk1 Protein Kinase and the Cdc25C Regulatory Pathways Are Targets of the Anticancer Agent UCN-01* , 2000, The Journal of Biological Chemistry.

[32]  Y Taya,et al.  The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. , 2000, Genes & development.

[33]  S. T. Kim,et al.  Substrate Specificities and Identification of Putative Substrates of ATM Kinase Family Members* , 1999, The Journal of Biological Chemistry.

[34]  T. Stankovic,et al.  The DNA Double-Strand Break Repair Gene hMRE11 Is Mutated in Individuals with an Ataxia-Telangiectasia-like Disorder , 1999, Cell.

[35]  Y. Shiloh,et al.  ATM: A mediator of multiple responses to genotoxic stress , 1999, Oncogene.

[36]  M. Broggini,et al.  CHK1 frameshift mutations in genetically unstable colorectal and endometrial cancers , 1999 .

[37]  S. Reed,et al.  Deregulated cyclin E induces chromosome instability , 1999, Nature.

[38]  Ingrid,et al.  Ectopic Expression of Cdc25A Accelerates the G1/S Transition and Leads to Premature Activation of Cyclin E- and Cyclin A-Dependent Kinases , 1999, Molecular and Cellular Biology.

[39]  K. Helin,et al.  CDC25A Phosphatase Is a Target of E2F and Is Required for Efficient E2F-Induced S Phase , 1999, Molecular and Cellular Biology.

[40]  M. Nakanishi,et al.  Cell cycle-dependent and ATM-independent expression of human Chk1 kinase , 1999, Oncogene.

[41]  S. Elledge,et al.  Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. , 1998, Science.

[42]  L. Mao,et al.  Overexpression of cdc25A and cdc25B is frequent in primary non-small cell lung cancer but is not associated with overexpression of c-myc. , 1998, Cancer research.

[43]  S. Elledge,et al.  Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. , 1997, Science.

[44]  Yosef Shiloh,et al.  Recombinant ATM protein complements the cellular A-T phenotype , 1997, Oncogene.

[45]  M. Loda,et al.  CDC25 phosphatases as potential human oncogenes. , 1995, Science.

[46]  C. Wernstedt,et al.  Identification of the Major Phosphorylation Sites for Protein Kinase C in Kit/Stem Cell Factor Receptor in Vitro and in Intact Cells (*) , 1995, The Journal of Biological Chemistry.

[47]  L. Hartwell,et al.  Cell cycle control and cancer. , 1994, Science.

[48]  R. Painter,et al.  Radiosensitivity in ataxia-telangiectasia: a new explanation. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[49]  A. Cameron,et al.  Radiosensitivity in ataxia-telangiectasia. , 1975, The British journal of radiology.

[50]  T. Hunter,et al.  Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. , 1991, Methods in enzymology.

[51]  E. Harlow,et al.  Antibodies: A Laboratory Manual , 1988 .

[52]  J. Campbell.  Eukaryotic DNA replication. , 1986, Annual review of biochemistry.